{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:07:49Z","timestamp":1770822469426,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1007\/s11864-005-0004-3","type":"journal-article","created":{"date-parts":[[2007,7,26]],"date-time":"2007-07-26T08:55:05Z","timestamp":1185440105000},"page":"209-214","source":"Crossref","is-referenced-by-count":17,"title":["Pediatric myelodysplastic syndromes"],"prefix":"10.1007","volume":"6","author":[{"given":"Charlotte Marie","family":"Niemeyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian Peter","family":"Kratz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Hasle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"4_CR1","unstructured":"Jaffe ES, Harris NL, Stein H, Vardiman JW: World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoetic and Lymphoid Tissues. Edited by Jaffe EJ, Harris NL, Stein H, Vardiman JW. Lyon: International Agency for Research on Cancer; 2001."},{"key":"4_CR2","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1182\/blood-2002-11-3444","volume":"102","author":"G Kardos","year":"2003","unstructured":"Kardos G, Baumann I, Passmore SJ, et al.: Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7. Blood 2003, 102:1997\u20132003. This paper reviews clinical courses observed in a large cohort of children with refractory cytopenia.","journal-title":"Blood"},{"key":"4_CR3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.leu.2402765","volume":"17","author":"H Hasle","year":"2003","unstructured":"Hasle H, Niemeyer CM, Chessells JM, et al.: A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Leukemia 2003, 17:277\u2013282. This paper summarizes the present classification scheme employed in pediatric myelodysplastic syndrome.","journal-title":"Leukemia"},{"key":"4_CR4","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1046\/j.1365-2141.2003.04361.x","volume":"121","author":"SJ Passmore","year":"2003","unstructured":"Passmore SJ, Chessells JM, Kempski H, et al.: Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia in the UK: a population-based study of incidence and survival. Br J Haematol 2003, 121:758\u2013767. This paper describes a large cohort of pediatric patients with myelodysplastic syndrome.","journal-title":"Br J Haematol"},{"key":"4_CR5","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1038\/sj.leu.2403489","volume":"18","author":"H Hasle","year":"2004","unstructured":"Hasle H, Baumann I, Bergstrasser E, et al.: The International Prognostic Scoring System (IPSS) for childhood myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML). Leukemia 2004, 18:2008\u20132014.","journal-title":"Leukemia"},{"key":"4_CR6","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood.V100.5.1570.h81702001570_1570_1574","volume":"100","author":"Y Saunthararajah","year":"2002","unstructured":"Saunthararajah Y, Nakamura R, Nam JM, et al.: HLADR15 (DR2) is over-represented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome. Blood 2002, 100:1570\u20131574.","journal-title":"Blood"},{"key":"4_CR7","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1182\/blood-2002-09-2867","volume":"101","author":"DP Steensma","year":"2003","unstructured":"Steensma DP, Dispenzieri A, Moore SB, et al.:Antithymocyte globulin has limited efficacy and substantial toxicity in unselected anemic patients with myelodysplastic syndrome. Blood 2003, 101:2156\u20132158.","journal-title":"Blood"},{"key":"4_CR8","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.1038\/sj.bmt.1703807","volume":"31","author":"AMJ Peters","year":"2003","unstructured":"Peters AMJ, Baumann I, Strahm B: Immunosuppressive therapy for children with refractory anemia [abstract]. Bone Marrow Transplant 2003, 31:S183.","journal-title":"Bone Marrow Transplant"},{"key":"4_CR9","first-page":"185","volume":"9","author":"G Hicsonmez","year":"1995","unstructured":"Hicsonmez G, Tuncer AM, Sayli T, et al.: High-dose methylprednisolone, low-dose cytosine arabinoside, and mitoxantrone in children with myelodysplastic syndromes. Hematol Pathol 1995, 9:185\u2013193.","journal-title":"Hematol Pathol"},{"key":"4_CR10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1365-2141.2002.03369.x","volume":"117","author":"DK Webb","year":"2002","unstructured":"Webb DK, Passmore SJ, Hann IM, et al.: Results of treatment of children with refractory anaemia with excess blasts (RAEB) and RAEB in transformation (RAEBt) in Great Britain 1990 to 1999. Br J Haematol 2002, 117:33\u201339.","journal-title":"Br J Haematol"},{"key":"4_CR11","first-page":"434","volume":"20","author":"WG Woods","year":"2002","unstructured":"Woods WG, Barnard DR, Alonzo TA, et al.: Prospective study of 90 children requiring treatment for juvenile myelomonocytic leukemia or myelodysplastic syndrome: a report from the Children\u2019s Cancer Group. J Clin Oncol 2002, 20:434\u2013440.","journal-title":"J Clin Oncol"},{"key":"4_CR12","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1038\/sj.leu.2402271","volume":"15","author":"H Sasaki","year":"2001","unstructured":"Sasaki H, Manabe A, Kojima S, et al.: Myelodysplastic syndrome in childhood: a retrospective study of 189 patients in Japan. Leukemia 2001, 15:1713\u20131720.","journal-title":"Leukemia"},{"key":"4_CR13","first-page":"1269","volume":"10","author":"H Hasle","year":"1996","unstructured":"Hasle H, Kerndrup G, Yssing M, et al.: Intensive chemotherapy in childhood myelodysplastic syndrome. A comparison with results in acute myeloid leukemia. Leukemia 1996, 10:1269\u20131273.","journal-title":"Leukemia"},{"key":"4_CR14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/sj.leu.2400558","volume":"11","author":"GC Chan","year":"1997","unstructured":"Chan GC, Wang WC, Raimondi SC, et al.: Myelodysplastic syndrome in children: differentiation from acute myeloid leukemia with a low-blast count. Leukemia 1997, 11:206\u2013211.","journal-title":"Leukemia"},{"key":"4_CR15","doi-asserted-by":"crossref","first-page":"632a","DOI":"10.1182\/blood.V104.11.2300.2300","volume":"104","author":"CM Niemeyer","year":"2004","unstructured":"Niemeyer CM, Zecca M, Korthoff E, et al.: Allogeneic stem cell transplantation for children with advanced primary MDS: results from the EWOG-MDS study group employing a pretransplant preparative regimen with busulfan, cyclophosphamide, and melphalan [abstract]. Blood 2004, 104:632a.","journal-title":"Blood"},{"key":"4_CR16","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/sj.bmt.1704438","volume":"33","author":"U Yusuf","year":"2004","unstructured":"Yusuf U, Frangoul HA, Gooley TA, et al.: Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience. Bone Marrow Transplant 2004, 33:805\u2013814.","journal-title":"Bone Marrow Transplant"},{"key":"4_CR17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/sj.bmt.1701517","volume":"23","author":"AM Leahey","year":"1999","unstructured":"Leahey AM, Friedman DL, Bunin NJ: Bone marrow transplantation in pediatric patients with therapyrelated myelodysplasia and leukemia. Bone Marrow Transplant 1999, 23:21\u201325.","journal-title":"Bone Marrow Transplant"},{"key":"4_CR18","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1182\/blood-2002-02-0527","volume":"100","author":"HJ Deeg","year":"2002","unstructured":"Deeg HJ, Storer B, Slattery JT, et al.: Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome. Blood 2002, 100:1201\u20131207.","journal-title":"Blood"},{"key":"4_CR19","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1038\/sj.leu.2401577","volume":"13","author":"C Peters","year":"1999","unstructured":"Peters C, Matthes-Martin S, Fritsch G: Transplantation of highly purified peripheral blood CD34+ cells from HLA-mismatched parental donors in 14 children: evaluation of early monitoring of engraftment. Leukemia 1999, 13:2070\u20132078.","journal-title":"Leukemia"},{"key":"4_CR20","first-page":"971","volume":"14","author":"F Locatelli","year":"2002","unstructured":"Locatelli F, Zecca M, Duffner U, et al.: Busulfan, cyclophosphamide, and melphalan as pretransplant conditioning regimen for children with myelodysplasia (MDS) and juvenile myelomonocytic leukaemia (JMML). Interim analysis of the EWOGMDS\/ EBMT prospective study. Leukemia 2002, 14:971.","journal-title":"Leukemia"},{"key":"4_CR21","doi-asserted-by":"crossref","unstructured":"List AF, Vardiman J, Issa JP, Dewitte TM: Myelodysplastic syndromes. Hematology (Am Soc Hematol Educ Program) 2004, 297\u2013317.","DOI":"10.1182\/asheducation-2004.1.297"},{"key":"4_CR22","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1182\/blood.V100.2.427","volume":"100","author":"DR Barnard","year":"2002","unstructured":"Barnard DR, Lange B, Alonzo TA, et al.: Acute myeloid leukemia and myelodysplastic syndrome in children treated for cancer: comparison with primary presentation. Blood 2002, 100:427\u2013434.","journal-title":"Blood"},{"key":"4_CR23","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1200\/JCO.2000.18.5.963","volume":"18","author":"I Yakoub-Agha","year":"2000","unstructured":"Yakoub-Agha I, de La SP, Ribaud P, et al.: Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia: a long-term study of 70 patients-report of the French society of bone marrow transplantation. J Clin Oncol 2000, 18:963\u2013971.","journal-title":"J Clin Oncol"},{"key":"4_CR24","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/sj.bmt.1701962","volume":"24","author":"GA Hale","year":"1999","unstructured":"Hale GA, Heslop HE, Bowman LC, et al.: Bone marrow transplantation for therapy-induced acute myeloid leukemia in children with previous lymphoid malignancies. Bone Marrow Transplant 1999, 24:735\u2013739.","journal-title":"Bone Marrow Transplant"},{"key":"4_CR25","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1046\/j.1365-2141.2000.02200.x","volume":"110","author":"T Witte de","year":"2000","unstructured":"de Witte T, Hermans J, Vossen J, et al.: Haematopoietic stem cell transplantation for patients with myelodysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol 2000, 110:620\u2013630.","journal-title":"Br J Haematol"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-005-0004-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11864-005-0004-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-005-0004-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T10:42:54Z","timestamp":1587811374000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11864-005-0004-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["4"],"URL":"https:\/\/doi.org\/10.1007\/s11864-005-0004-3","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}